This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Danaher Shareholders Back Directors, Pay Plan and Auditor

Tipranks - Fri May 8, 6:36PM CDT

Claim 55% Off TipRanks

Danaher ( (DHR) ) has provided an announcement.

At Danaher Corporation’s annual meeting of shareholders held on May 5, 2026, investors elected eleven directors to serve terms expiring in 2027, with each nominee receiving substantial majority support. Shareholders also ratified Ernst & Young LLP as the independent registered public accounting firm for the 2026 fiscal year, reinforcing continuity in the company’s audit oversight.

In advisory and governance matters, shareholders approved the company’s named executive officer compensation and gave their backing to a new plan, both by solid margins despite a notable level of dissent votes. The outcomes collectively signal broad investor support for Danaher’s current leadership, compensation framework, and strategic direction, providing stability in the company’s corporate governance structure for the coming year.

The most recent analyst rating on (DHR) stock is a Buy with a $184.04 price target. To see the full list of analyst forecasts on Danaher stock, see the DHR Stock Forecast page.

Spark’s Take on DHR Stock

According to Spark, TipRanks’ AI Analyst, DHR is a Neutral.

DHR scores best on financial quality and the latest earnings call (strong cash generation, solid margins, raised EPS outlook), but the overall score is pulled down by clearly weak technicals (below key moving averages with negative MACD) and a relatively expensive valuation (P/E ~31 with a low yield).

To see Spark’s full report on DHR stock, click here.

More about Danaher

Danaher Corporation is a diversified global science and technology company that operates across life sciences, diagnostics, and environmental and applied solutions. The company develops and sells a broad range of instruments, consumables, and services used by healthcare, industrial, and research customers, with a focus on innovation and operational excellence to support long-term growth.

Average Trading Volume: 4,398,213

Technical Sentiment Signal: Sell

Current Market Cap: $123.8B

For a thorough assessment of DHR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.